CTRI/2018/02/011668已完成2 期
Clinical evaluation of virechana karma in the management of diabetes mellitus type II
Rishikul campus Uttarakhanad Ayurveda university haridwar0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Patients having sign & symptoms of Diabetes Mellitus type II.
- •2.Fasting blood glucose level > 110 mg/dl
- •3.P.P blood sugar level > 140 mg/dl
- •4.HbA1c > 6.0% or above 42 mmol/mol
- •5.Patients eligible for Virechana Karma.
排除标准
- •1.Patient with D.M Type I.
- •2.Patients suffering from secondary diabetes.
- •3.Patients suffering from any severe systemic illness.
- •4.Hypertensive patient with B.P > 200/100 mm of Hg.
- •5.Patients suffering from Diabetogenic Renal complications.
- •6.Other contraindication for Virechanakarma indicated in text.
研究者
相似试验
招募中
2 期
Effect of Virechana Karma on Metabolic SyndromeCTRI/2017/06/008934Rishikul Campus Uttarakhand Ayurved University30
尚未招募
2 期
Effect of virechana karma with Gandharvahastadi kwath in the management of Aamvat w.s.r. to rheumatoid arthritisCTRI/2024/05/067141Government Ayurvedic College and Hospital Kadamkuan Patna
尚未招募
Unknown
A clinical trial to study the effect of Virechana Karma and Jalkumbhi bhasma in patients of hypothyroidismCTRI/2023/07/055852ttarakhand Ayurved University
尚未招募
不适用
A clinical trial to study the effects of two therapies,Virechana karma and Edagajadi Lepa in patients with Vicharchika ( Eczema)CTRI/2022/08/044561Rishikul campus
尚未招募
2 期
Purgation with misraka sneha in treating rheumatoid arthritisCTRI/2024/06/069512DrSindhoora V Prabhu